Apr 9, 2021
|
Initial S-1
|
Apr 27, 2021
|
Amended S-1
Sign In
to view filing content.
|
May 19, 2021
|
Amended S-1
Sign In
to view filing content.
|
May 27, 2021
|
PR announcing pricing of $100mm IPO
Sign In
to view filing content.
|
Jun 1, 2021
|
424B4 IPO Prospectus
|
Jun 24, 2021
|
8-K announcing partial over-allotment exercise
Sign In
to view filing content.
|
Jul 16, 2021
|
PR announcing separate trading of shares and warrants
Sign In
to view filing content.
|
May 23, 2022
|
8-K announcing sponsor contribution to trust in connection with extension
Sign In
to view filing content.
|
Jun 2, 2022
|
PR announcing sponsor contribution to trust in connection with extension
Sign In
to view filing content.
|
Aug 10, 2022
|
8-K announcing business combination with Captura Biopharma
Sign In
to view filing content.
|
Oct 11, 2022
|
PRE14A Preliminary proxy for charter extension meeting
Sign In
to view filing content.
|
Oct 13, 2022
|
PR announcing termination of Captura Biopharma business combination
Sign In
to view filing content.
|
Oct 28, 2022
|
DEF14A Definitive proxy for charter extension meeting
Sign In
to view filing content.
|
Nov 15, 2022
|
8-K announcing business combination with Majic Wheels Corp
Sign In
to view filing content.
|
Nov 16, 2022
|
8-K announcing change in Directors
Sign In
to view filing content.
|
Nov 21, 2022
|
8-K with full Majic Wheels Corp merger agreement
Sign In
to view filing content.
|
Nov 22, 2022
|
PR announcing postponement of charter extension meeting
Sign In
to view filing content.
|
Dec 1, 2022
|
PR announcing shareholder approval for charter extension meeting
Sign In
to view filing content.
|
Dec 2, 2022
|
8-K with extension meeting results
Sign In
to view filing content.
|
Jan 3, 2023
|
8-K confirming funding of extension payment
Sign In
to view filing content.
|
Feb 6, 2023
|
8-K announcing termination of Majic Wheels business combination
Sign In
to view filing content.
|
Feb 6, 2023
|
8-K confirming funding of extension payment
Sign In
to view filing content.
|
Mar 2, 2023
|
PR confirming funding of extension payment
Sign In
to view filing content.
|
Mar 13, 2023
|
8-K announcing change in directors and transfer of sponsor ownership
Sign In
to view filing content.
|
Mar 31, 2023
|
8-K confirming funding of extension payment
Sign In
to view filing content.
|
Apr 26, 2023
|
PRE14A Preliminary Proxy for charter extension meeting
Sign In
to view filing content.
|
May 3, 2023
|
8-K announcing business combination with Regentis Biomaterials and confirming funding of extension payment
Sign In
to view filing content.
|
May 8, 2023
|
8-K with full Regentis Biomaterials merger agreement
Sign In
to view filing content.
|
May 9, 2023
|
DEF14A Definitive Proxy for charter extension meeting
Sign In
to view filing content.
|
May 10, 2023
|
8-K with updated estimated per share redemption price
Sign In
to view filing content.
|
May 19, 2023
|
8-K announcing updated sponsor contribution to trust in connection with proposed extension
Sign In
to view filing content.
|
May 25, 2023
|
PR announcing postponement of charter extension meeting
Sign In
to view filing content.
|
May 30, 2023
|
8-K with extension meeting results
Sign In
to view filing content.
|
Jun 1, 2023
|
8-K confirming funding of extension payment
Sign In
to view filing content.
|
Jun 27, 2023
|
8-K confirming funding of extension payment
Sign In
to view filing content.
|
Jul 10, 2023
|
S-4 registration statement containing preliminary proxy for Regentis Biomaterials business combination
Sign In
to view filing content.
|
Jul 27, 2023
|
8-K with notice of delisting
Sign In
to view filing content.
|
Jul 31, 2023
|
8-K confirming funding of extension payment
Sign In
to view filing content.
|
Aug 8, 2023
|
PRE14A preliminary proxy for founder share amendment meeting
Sign In
to view filing content.
|
Aug 23, 2023
|
DEF14A Definitive proxy for founder share amendment meeting
Sign In
to view filing content.
|
Aug 31, 2023
|
8-K confirming funding of extension payment
Sign In
to view filing content.
|
Sep 6, 2023
|
8-K with Founder Share Amendment meeting results
Sign In
to view filing content.
|
Sep 13, 2023
|
S-4/A Amendment #1 to registration statement containing preliminary proxy for Regentis Biomaterials business combination
Sign In
to view filing content.
|
Sep 27, 2023
|
8-K confirming funding of extension payment
Sign In
to view filing content.
|
Oct 30, 2023
|
8-K confirming funding of extension payment
Sign In
to view filing content.
|
Nov 3, 2023
|
S-4/A Amendment #2 to registration statement containing preliminary proxy for Regentis Biomaterials business combination
Sign In
to view filing content.
|
Nov 13, 2023
|
8-K with investor presentation
Sign In
to view filing content.
|
Nov 27, 2023
|
8-K confirming funding of extension payment
Sign In
to view filing content.
|
Dec 21, 2023
|
S-4/A Amendment #3 to registration statement containing preliminary proxy for Regentis Biomaterials business combination
Sign In
to view filing content.
|
Dec 27, 2023
|
8-K confirming funding of extension payment
Sign In
to view filing content.
|
Dec 29, 2023
|
S-4/A Amendment #4 to registration statement containing preliminary proxy for Regentis Biomaterials business combination
|
Dec 29, 2023
|
S-4/A Amendment #5 to registration statement containing preliminary proxy for Regentis Biomaterials business combination
|
Jan 2, 2024
|
424B3 Definitive proxy for Regentis Biomaterials business combination
Sign In
to view filing content.
|
Jan 19, 2024
|
8-K announcing postponement of Regentis Biomaterials approval meeting
Sign In
to view filing content.
|
Jan 24, 2024
|
8-K with update on delisting from NASDAQ
Sign In
to view filing content.
|
Jan 30, 2024
|
8-K confirming funding of extension payment
Sign In
to view filing content.
|
Feb 13, 2024
|
8-K with Regentis Biomaterials meeting results
Sign In
to view filing content.
|
Mar 4, 2024
|
8-K confirming funding of extension payment
Sign In
to view filing content.
|
Apr 4, 2024
|
8-K confirming funding of extension payment
Sign In
to view filing content.
|
Apr 29, 2024
|
8-K announcing anticipated $10mm equity line purchase agreement
Sign In
to view filing content.
|
May 2, 2024
|
8-K confirming funding of extension payment
Sign In
to view filing content.
|
Jun 5, 2024
|
8-K announcing termination of Regentis Biomaterials business combination and subsequent liquidation
Sign In
to view filing content.
|